000796622 000__ 03299cam\a2200529M\\4500
000796622 001__ 796622
000796622 005__ 20230306143539.0
000796622 006__ m\\\\\o\\d\\\\\\\\
000796622 007__ cr\un\nnnunnun
000796622 008__ 170804s2017\\\\xx\\\\\\o\\\\\000\0\eng\d
000796622 019__ $$a999606505$$a1000023835
000796622 020__ $$a9783319547411$$q(electronic book)
000796622 020__ $$a3319547410$$q(electronic book)
000796622 020__ $$z9783319547404
000796622 020__ $$z3319547402
000796622 035__ $$aSP(OCoLC)ocn999564918
000796622 035__ $$aSP(OCoLC)999564918$$z(OCoLC)999606505$$z(OCoLC)1000023835
000796622 040__ $$aYDX$$beng$$cYDX$$dN$T$$dEBLCP$$dNJR$$dKOS$$dGW5XE$$dKOS$$dN$T$$dOCLCO$$dUAB$$dOCLCO
000796622 049__ $$aISEA
000796622 050_4 $$aRC280.M37
000796622 050_4 $$aR1
000796622 08204 $$a616.07548
000796622 24500 $$aPET/CT in melanoma /$$cMichael S. Hofman, Rodney J. Hicks, editors.
000796622 260__ $$a[S.l.] :$$bSpringer,$$c2017.
000796622 300__ $$a1 online resource.
000796622 336__ $$atext$$btxt$$2rdacontent
000796622 337__ $$acomputer$$bc$$2rdamedia
000796622 338__ $$aonline resource$$bcr$$2rdacarrier
000796622 4901_ $$aClinicians' guides to radionuclide hybrid imaging, PET/CT
000796622 5050_ $$aForeword; Preface; Acknowledgements; Contents; Contributors; 1: Melanoma; 1.1 Clinical Features; 1.2 Biopsy of the Lesion; 1.3 Classification; 1.3.1 Superficial Spreading Melanoma; 1.3.2 Nodular Melanoma; 1.3.3 Lentigo Maligna Melanoma (LMM); 1.3.4 Acrolentiginous Melanoma (ALM); 1.4 Classification/Staging; References; 2: Pathology of Melanoma; 2.1 Histopathology; 2.2 Sentinel Lymph Node Biopsy; 2.3 Synoptic Reporting of Melanoma; 2.4 Molecular Analysis; References; 3: Management of Melanoma; 3.1 Surgical Management of Primary Melanoma; 3.2 Sentinel Lymph Node Biopsy
000796622 5058_ $$a3.3 Management of Locoregional Recurrent Melanoma3.4 Radiotherapy; 3.5 Adjuvant Systemic Therapy of Melanoma; 3.6 Management of Metastatic Melanoma; 3.6.1 Targeted Systemic Therapy with MAPK Pathway Inhibition; 3.6.2 Immunotherapy; 3.6.3 Cytotoxic Chemotherapy; References; 4: Radiological Imaging in Melanoma; 4.1 Introduction; 4.2 Plain Radiographs; 4.3 Ultrasound; 4.4 Computerised Tomography (CT); 4.5 MRI; 4.6 Restaging Imaging; References; 5: Role of PET/CT in Melanoma; 5.1 Introduction; 5.2 Primary Diagnosis/Staging; 5.2.1 Sentinel Lymph Node Scintigraphy with SPECT/CT
000796622 5058_ $$a5.2.2 Sentinel Lymph Node Positive5.2.3 High-Risk Patients with Stage I or II Disease; 5.2.4 Stage III and IV Melanoma; 5.2.5 Limitations of FDG PET/CT; 5.3 Response Assessment; 5.3.1 Pitfalls; 5.3.2 Treatment Related Adverse Effects Mimicking Malignancy; 5.4 Surveillance; 5.5 Beyond FDG PET/CT; References; 6: PET/CT in Melanoma (Additional Teaching Cases); References; Index
000796622 506__ $$aAccess limited to authorized users.
000796622 588__ $$aDescription based on print version record.
000796622 650_0 $$aMelanoma$$xTomography.
000796622 650_0 $$aTomography, Emission.
000796622 650_0 $$aMedicine.
000796622 650_0 $$aNuclear medicine.
000796622 650_0 $$aOncology.
000796622 7001_ $$aHofman, Michael S.
000796622 7001_ $$aHicks, Rodney J.
000796622 77608 $$iPrint version:$$z3319547402$$z9783319547404$$w(OCoLC)971355356
000796622 830_0 $$aClinicians' guides to radionuclide hybrid imaging.$$pPET/CT.
000796622 852__ $$bebk
000796622 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-54741-1$$zOnline Access$$91397441.1
000796622 909CO $$ooai:library.usi.edu:796622$$pGLOBAL_SET
000796622 980__ $$aEBOOK
000796622 980__ $$aBIB
000796622 982__ $$aEbook
000796622 983__ $$aOnline
000796622 994__ $$a92$$bISE